Top Markets
#1 EXOD EXOD +22.08%
#2 Geodnet Geodnet +17.40%
#3 Neiro Neiro +17.31%
#4 XPIN Network XPIN Network +16.45%
#5 Derive Derive +16.18%
#6 Mubarak Mubarak +14.79%
#7 AUKI AUKI +14.02%
#8 Pons Pons +13.99%
#9 Status Status +13.41%
#10 The Black Bull The Black Bull +13.26%
Coin of the day
EXOD EXOD
Настройки
Язык
Pусский
Валюта
USD
Тема
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Ранг среди акций #25183
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Цена акции
$1.95
Последняя синхронизация: 2022-07-29
Рыночная капитализация
$52.48M
Изменение (1 день)
2.63%
Изменение (1 год)
0.00%
Страна
US
Торговля Cortexyme, Inc. (CRTX)

Категория

Healthcare
История цены акций Cortexyme, Inc. (CRTX)
Наивысшая цена закрытия: $2.18 2022-07-01

Наименьшая цена закрытия: $26.37 2019-05-01
История цены акций Cortexyme, Inc. с 2019 по 2026
Годовая динамика цены акций
Год Результативность
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US